UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK

PLoS medicine, 2005-01, Vol.2 (1), p.e18-e18

2005

Volltextzugriff (PDF)

Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels

Neurobiology of disease, 2006-06, Vol.22 (3), p.651-656

2006

Volltextzugriff (PDF)

American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting Pre‐Conferences

CPT: pharmacometrics and systems pharmacology, 2019-06, Vol.8 (6), p.333-335

2019

Volltextzugriff (PDF)

A Librarian's Role in Improving Rigor in Research-AlzPED: Alzheimer's Disease Preclinical Efficacy Database

Science & technology libraries (New York, N.Y.), 2017-07, Vol.36 (3), p.296-308

2017

Volltextzugriff (PDF)

Statin therapy for Alzheimer's disease: will it work?

Journal of molecular neuroscience, 2002-08, Vol.19 (1-2), p.155-161

2002

Volltextzugriff (PDF)

Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications

Amyloid, 2007, Vol.14 (1), p.21-32

2007

Volltextzugriff (PDF)

Exploring the links between obesity and Alzheimer's disease

Current Alzheimer research, 2007-04, Vol.4 (2), p.95

Petanceska, Suzana S

2007

Volltextzugriff (PDF)

Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD

Current Alzheimer research, 2005-07, Vol.2 (3), p.343-353

2005

Volltextzugriff (PDF)

Alzheimer’s Disease Preclinical Efficacy Database (AlzPED): Optimizing the Scientific Rigor and Reproducibility of Preclinical Research in Alzheimer’s Disease

Alzheimer's & dementia, 2022-12, Vol.18 (S10), p.n/a

2022

Volltextzugriff (PDF)

Expression of Rat Cathepsin S in Phagocytic Cells (∗)

The Journal of biological chemistry, 1996-02, Vol.271 (8), p.4403-4409

1996

Volltextzugriff (PDF)

AlzPED: Optimizing the predictive power of drug efficacy studies in Alzheimer’s disease animal models

Alzheimer's & dementia, 2021-12, Vol.17 (S9), p.n/a

2021

Volltextzugriff (PDF)

Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβ peptides and F2‐isoprostanes in the absence of detectable amyloid deposits

Journal of neurochemistry, 2004-08, Vol.90 (4), p.1011-1018

2004

Volltextzugriff (PDF)

Cholesterol, Copper and Aβ in Controls, MCI, AD and the AD Cholesterol- Lowering Treatment Trial (ADCLT)

Current Alzheimer research, 2005-12, Vol.2 (5), p.527-539

2005

Volltextzugriff (PDF)

Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol

Journal of molecular neuroscience, 2003-01, Vol.20 (3), p.395-406

2003

Volltextzugriff (PDF)

Age-associated androgen deficiency and Alzheimer's disease: a case in the making?

Journal of Alzheimer's disease, 2003-08, Vol.5 (4), p.271-273

Petanceska, Suzana S

2003

Volltextzugriff (PDF)

Evidence for Phosphorylation and Oligomeric Assembly of Presenilin 1

Proceedings of the National Academy of Sciences - PNAS, 1997-05, Vol.94 (10), p.5090-5094

1997

Volltextzugriff (PDF)

AlzPED: Improving the predictive power and translational validity of preclinical testing of candidate therapeutics in Alzheimer’s disease animal models: Development of new models and analysis methods/validation of pre‐clinical methods

Alzheimer's & dementia, 2020-12, Vol.16 (S3)

2020

Volltextzugriff (PDF)

AlzPED: Improving the predictive power and translational validity of preclinical testing of candidate therapeutics in Alzheimer’s disease animal models

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome

PLoS genetics, 2021-01, Vol.17 (1), p.e1009224

2021

Volltextzugriff (PDF)

P4‐075: ALZPED: A NEW DATA RESOURCE FOR IMPROVING THE RIGOR, TRANSPARENCY, REPRODUCIBILITY AND TRANSLATION OF ALZHEIMER'S DISEASE PRECLINICAL RESEARCH

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_25), p.P1303-P1303

2019

Volltextzugriff (PDF)

ALZPED: A NEW DATA RESOURCE FOR IMPROVING THE RIGOR, TRANSPARENCY, REPRODUCIBILITY AND TRANSLATION OF ALZHEIMER'S DISEASE PRECLINICAL RESEARCH

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P1303-P1303

2019

Volltextzugriff (PDF)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers

JAMA network open, 2019-07, Vol.2 (7), p.e197978

2019

Volltextzugriff (PDF)

The Phosphatidylinositol 3‐Kinase Inhibitor Wortmannin Alters the Metabolism of the Alzheimer's Amyloid Precursor Protein

Journal of neurochemistry, 1999-12, Vol.73 (6), p.2316-2320

1999

Volltextzugriff (PDF)

Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

Neurobiology of aging, 2004-11, Vol.25 (10), p.1263-1272

2004

Volltextzugriff (PDF)

Editorial [Hot Topic: Exploring the Links between Obesity and Alzheimers Disease (Guest Editor: Suzana S. Petanceska) ]

Current Alzheimer research, 2007-04, Vol.4 (2), p.95-96

Petanceska, Suzana

2007

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(68)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK

Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels

American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting Pre‐Conferences

A Librarian's Role in Improving Rigor in Research-AlzPED: Alzheimer's Disease Preclinical Efficacy Database

Statin therapy for Alzheimer's disease: will it work?

Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications

Exploring the links between obesity and Alzheimer's disease

Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD

Alzheimer’s Disease Preclinical Efficacy Database (AlzPED): Optimizing the Scientific Rigor and Reproducibility of Preclinical Research in Alzheimer’s Disease

Expression of Rat Cathepsin S in Phagocytic Cells (∗)

AlzPED: Optimizing the predictive power of drug efficacy studies in Alzheimer’s disease animal models

Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβ peptides and F2‐isoprostanes in the absence of detectable amyloid deposits

Cholesterol, Copper and Aβ in Controls, MCI, AD and the AD Cholesterol- Lowering Treatment Trial (ADCLT)

Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol

Age-associated androgen deficiency and Alzheimer's disease: a case in the making?

Evidence for Phosphorylation and Oligomeric Assembly of Presenilin 1

AlzPED: Improving the predictive power and translational validity of preclinical testing of candidate therapeutics in Alzheimer’s disease animal models: Development of new models and analysis methods/validation of pre‐clinical methods

AlzPED: Improving the predictive power and translational validity of preclinical testing of candidate therapeutics in Alzheimer’s disease animal models

Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome

P4‐075: ALZPED: A NEW DATA RESOURCE FOR IMPROVING THE RIGOR, TRANSPARENCY, REPRODUCIBILITY AND TRANSLATION OF ALZHEIMER'S DISEASE PRECLINICAL RESEARCH

ALZPED: A NEW DATA RESOURCE FOR IMPROVING THE RIGOR, TRANSPARENCY, REPRODUCIBILITY AND TRANSLATION OF ALZHEIMER'S DISEASE PRECLINICAL RESEARCH

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers

The Phosphatidylinositol 3‐Kinase Inhibitor Wortmannin Alters the Metabolism of the Alzheimer's Amyloid Precursor Protein

Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

Editorial [Hot Topic: Exploring the Links between Obesity and Alzheimers Disease (Guest Editor: Suzana S. Petanceska) ]

Suchergebnisse filtern